Quotes 5-day view Delayed Nasdaq
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
32.69(c)
32.58(c)
33.82(c)
38.42(c)
36.88(c)
Last
496 396
523 953
1 167 999
1 840 702
1 018 611
Volume
+0.43% -0.34% +3.81% +13.60% -4.01% Change
Sales 2020
4 273 M - -
Net income 2020
-23,0 M - -
Net Debt 2020
674 M - -
P/E ratio 2020
-154x
Yield 2020
-
Sales 2021
4 478 M - -
Net income 2021
24,4 M - -
Net Debt 2021
527 M - -
P/E ratio 2021
194x
Yield 2021
-
Capitalization
4 703 M 4 703 M -
EV / Sales 2020
1,26x
EV / Sales 2021
1,17x
Nbr of Employees
5 300
Free-Float
72,5%
Covetrus, Inc is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy...
Notations Surperformance© of Covetrus, Inc.
Trading Rating : Investor Rating :
All news about COVETRUS, INC.
News in other languages on COVETRUS, INC.
Analyst Recommendations on COVETRUS, INC.
COVETRUS, INC. - 2020
The stock is approaching a major resistance level
BUY
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends COVETRUS, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
7
Average target price
30,00 $
Last Close Price
36,88 $
Spread / Highest target
-5,10%
Spread / Average Target
-18,7%
Spread / Lowest Target
-34,9%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
